Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet — FDA Drug Shortage
The FDA lists a drug shortage record for Amphetamine Aspartate Monohydrate, Amphetamine Sulfate, Dextroamphetamine Saccharate, Dextroamphetamine Sulfate Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Oct 12, 2022.
Shortage details
- Status
- Current
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 57844-110-01
- Dosage Form
- Tablet
- Presentation
- Adderall, Tablet, 2.5 mg; 2.5 mg; 2.5 mg; 2.5 mg (NDC 57844-110-01)
- Initial Posting
- Oct 12, 2022